Monroe E W
Milwaukee Medical Clinic, WI.
J Am Acad Dermatol. 1988 Nov;19(5 Pt 1):842-9. doi: 10.1016/s0190-9622(88)70243-1.
Antihistamines are the drugs of choice in the symptomatic relief of chronic urticaria; however, the usefulness of classic antihistamines has been limited by side effects, especially daytime sedation. In the 1980s a new class of antihistamines has been developed that maintains effectiveness and produces less sedation. This review analyzes each of the new nonsedating antihistamines and evaluates its clinical efficacy, safety, and convenience in the treatment of chronic urticaria.
抗组胺药是缓解慢性荨麻疹症状的首选药物;然而,传统抗组胺药的效用受到副作用的限制,尤其是日间镇静作用。20世纪80年代研发出了一类新型抗组胺药,其疗效得以维持且镇静作用较小。本综述分析了每种新型非镇静性抗组胺药,并评估了其在治疗慢性荨麻疹方面的临床疗效、安全性和便利性。